Ki Won Park

Title: Ki Won Park: Innovator in Hydantoin Compounds

Introduction

Ki Won Park is a notable inventor based in Taejon, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of anti-cancer agents. His innovative work has led to the creation of novel compounds that hold promise for cancer treatment.

Latest Patents

Ki Won Park holds a patent for hydantoin compounds and methods related thereto. This invention involves novel hydantoin compounds represented by a specific formula, which exhibit inhibitory activity against farnesyl transferase. These compounds can potentially be used as anti-cancer agents or in pharmaceutically acceptable salts. The patent also details a process for preparing these compounds and includes an anti-cancer composition comprising the active ingredient.

Career Highlights

Ki Won Park is associated with LG Chemical Ltd., a leading company in the chemical industry. His work at the company has focused on the development of innovative pharmaceutical solutions. His expertise in medicinal chemistry has positioned him as a key player in the research and development of new therapeutic agents.

Collaborations

Ki Won Park has collaborated with notable colleagues, including Jin Ho Lee and Jong Sung Koh. These collaborations have fostered a productive research environment, leading to advancements in their respective fields.

Conclusion

Ki Won Park's contributions to the field of medicinal chemistry, particularly through his patent on hydantoin compounds, highlight his role as an innovator in the fight against cancer. His work continues to inspire advancements in pharmaceutical research and development.